Correction: the N-terminal phosphodegron targets TAZ/ WWTR1 protein for SCF-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition(Journal of Biological Chemistry (2012) 287:31(26245-53) DOI: 10.1074/jbc.M112.382036);The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCF β-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition

Journal of Biological Chemistry

Volumn 287, Issue 31, 2012, Pages 26245-26253

  Huang, Wei ^a,b,c   Lv, Xianbo ^a,b,c   Liu, Chenying ^a,b,c   Zha, Zhengyu ^b   Zhang, Heng ^a,b,c   Jiang, Ying ^b   Xiong, Yue ^b,c,d   Lei, Qun Ying ^a,b   Guan, Kun Liang ^a,b,e  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DISEASES; PHOSPHORYLATION; PROTEINS; TUMORS;

CORE COMPONENTS; PDZ BINDING MOTIF; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL CO-ACTIVATORS; TUMOR DEVELOPMENT; TUMOR SUPPRESSORS; UBIQUITIN LIGASES; UBIQUITYLATION;

CELL SIGNALING;

GLYCOGEN SYNTHASE KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SCF BETA TRCP; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL COACTIVATOR WITH PDZ BINDING MOTIF PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BIOACCUMULATION; CARBOXY TERMINAL SEQUENCE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; INTRACELLULAR SIGNALING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION; UBIQUITINATION;

EID: 84864387121     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC119.008437     Document Type: Erratum

References (37)

1. Harvey, K., and Tapon, N. (2007) The Salvador-Warts-Hippo pathway.An emerging tumor suppressor network. Nat. Rev. Cancer 7, 182-191
2. Pan, D. (2007) Hippo signaling in organ size control. Genes Dev. 21, 886-897
3. Saucedo, L. J., and Edgar, B. A. (2007) Filling out the Hippo pathway. Nat. Rev. Mol. Cell Biol. 8, 613-621 (Pubitemid 47106618)
4. Lei, Q. Y., Zhang, H., Zhao, B., Zha, Z. Y., Bai, F., Pei, X. H., Zhao, S., Xiong, Y., and Guan, K. L. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol. Cell. Biol. 28, 2426-2436 (Pubitemid 351429986)
5. Lai, Z. C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L. L., and Li, Y. (2005) Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats. Cell 120, 675-685 (Pubitemid 40343079)
6. Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C., Schiripo, T. A., Haber, D. A., and Hariharan, I. K. (2002) Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478 (Pubitemid 35232290)
7. Edgar, B. A. (2006) From cell structure to transcription. Hippo forges a new path. Cell 124, 267-273
8. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (Pubitemid 350070721)
9. Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., and Yaffe, M. B. (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19, 6778-6791 (Pubitemid 32011671)
10. Hong, J. H., Hwang, E. S., McManus, M. T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegelman, B. M., Sharp, P. A., Hopkins, N., and Yaffe, M. B. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078 (Pubitemid 41134465)
11. Hong, J. H., and Yaffe, M. B. (2006) TAZ. A β-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 5, 176-179
12. Mahoney, W. M., Jr., Hong, J. H., Yaffe, M. B., and Farrance, I. K. (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388, 217-225 (Pubitemid 40732949)
13. Murakami, M., Nakagawa, M., Olson, E. N., and Nakagawa, O. (2005) A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 18034-18039 (Pubitemid 41798497)
14. Park, K. S., Whitsett, J. A., Di Palma, T., Hong, J. H., Yaffe, M. B., and Zannini, M. (2004) TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J. Biol. Chem. 279, 17384-17390 (Pubitemid 38560499)
15. Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., and Hong, W. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592-2598 (Pubitemid 351556257)
16. Makita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., Nakagawa, O., Small, E. V., Cobo-Stark, P., Igarashi, P., Murakami, M., Tominaga, J., Sato, T., Asano, T., Kurihara, Y., and Kurihara, H. (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. Renal Physiol. 294, F542-F553 (Pubitemid 351442224)
17. Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W., and Hunziker, W. (2007) Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. U.S.A 104, 1631-1636 (Pubitemid 46214642)
18. Zhang, H., Liu, C. Y., Zha, Z. Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2009) TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355-13362
19. de Cristofaro, T., Di Palma, T., Ferraro, A., Corrado, A., Lucci, V., Franco, R., Fusco, A., and Zannini, M. (2011) TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur. J. Cancer 47, 926-933
20. Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M. S., and Yang, X. (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30, 2181-2186
21. Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., Daidone, M. G., Dupont, S., Basso, G., Bicciato, S., and Piccolo, S. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772
22. Bhat, K. P., Salazar, K. L., Balasubramaniyan, V., Wani, K., Heathcock, L., Hollingsworth, F., James, J. D., Gumin, J., Diefes, K. L., Kim, S. H., Turski, A., Azodi, Y., Yang, Y., Doucette, T., Colman, H., Sulman, E. P., Lang, F. F., Rao, G., Copray, S., Vaillant, B. D., and Aldape, K. D. (2011) The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 25, 2594-2609
23. Liu, C. Y., Zha, Z. Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., Zhao, S., Xiong, Y., Lei, Q. Y., and Guan, K. L. (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169
24. Tian, Y., Kolb, R., Hong, J. H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M. B., Zhou, J., and Benjamin, T. (2007) TAZ promotes PC2 degradation through a SCFβ-Trcp E3 ligase complex. Mol. Cell. Biol. 27, 6383-6395 (Pubitemid 47435745)
25. Cohen, P., and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776 (Pubitemid 33679839)
26. Zhao, B., Li, L., Tumaneng, K., Wang, C. Y., and Guan, K. L. (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(β-TRCP). Genes Dev. 24, 72-85
27. Zhao, B., Li, L., and Guan, K. L. (2010) Hippo signaling at a glance. J. Cell Sci. 123, 4001-4006
28. Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., and Roberts, J. M. (2003) Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12, 381-392 (Pubitemid 37238925)
29. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. (1998) Down-regulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr. Biol. 8, 573-581 (Pubitemid 28222891)
30. Diehl, J. A., Cheng, M., Roussel, M. F., and Sherr, C. J. (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511 (Pubitemid 28553242)
31. Alt, J. R., Cleveland, J. L., Hannink, M., and Diehl, J. A. (2000) Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1- dependent cellular transformation. Genes Dev. 14, 3102-3114 (Pubitemid 32015129)
32. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (Pubitemid 26004411)
33. Leevers, S. J., Weinkove, D., MacDougall, L. K., Hafen, E., and Waterfield, M. D. (1996) The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584-6594 (Pubitemid 26413791)
34. Verdu, J., Buratovich, M. A., Wilder, E. L., and Birnbaum, M. J. (1999) Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1, 500-506 (Pubitemid 129503670)
35. Zhao, J. J., and Roberts, T. M. (2006) PI3 kinases in cancer. From oncogene artifact to leading cancer target. Sci. STKE 2006, pe52
36. Vogt, P. K., Kang, S., Elsliger, M. A., and Gymnopoulos, M. (2007) Cancer-specific mutations in phosphatidylinositol 3-kinase. Trends Biochem. Sci. 32, 342-349 (Pubitemid 47021415)
37. Chan, S. W., Lim, C. J., Huang, C., Chong, Y. F., Gunaratne, H. J., Hogue, K. A., Blackstock, W. P., Harvey, K. F., and Hong, W. (2011) WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30, 600-610